Sarepta’s Medical Director, Clinical Development discusses the company’s upcoming ENVISION study for SRP-9001. 3 years ago Research & Clinical Trial Webinars,Webinars You may also like 54:28 Capricor Therapeutics: CAP-1002 HOPE-3 Program Update 3 years ago Research & Clinical Trial Webinars,Webinars capricor 49:31 Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy 3 years ago Research & Clinical Trial Webinars,Webinars edg-5506,edgewise 59:38 Supporting Families Through Decision Making 3 years ago Care Webinars,Webinars palliative care 52:31 Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO 3 years ago Research & Clinical Trial Webinars,Webinars 31:23 Advocating for Access: Insurance 101 3 years ago Care Webinars,Webinars 29:12 Advocating for Access: Navigating Approved Therapies in Duchenne 3 years ago Care Webinars,Webinars 1:11:00 Webinar: ELEVIDYS Approval: What this means for you and your family 3 years ago Care Webinars,Webinars 37:54 Community Town Hall: SRP-9001 Advisory Committee Update (May 2023) 3 years ago Research & Clinical Trial Webinars,Webinars «1…678910…29»Page 8 of 29